Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Development of an effective vaccine for prevention of infection with HIV would provide an important mechanism for controlling the AIDS epidemic. In the current study, the first clinical trial of a candidate HIV-1 vaccine initiated in the United States, the safety and immunogenicity of escalating dos...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Invest
Auteurs principaux: Kovacs, J A, Vasudevachari, M B, Easter, M, Davey, R T, Falloon, J, Polis, M A, Metcalf, J A, Salzman, N, Baseler, M, Smith, G E
Format: Artigo
Langue:Inglês
Publié: American Society for Clinical Investigation 1993
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC294931/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7688766/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116667
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires